Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-31 @ 9:33 PM
Study NCT ID:
NCT01593332
Status:
COMPLETED
Last Update Posted:
2012-05-08
First Post:
2012-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
Sponsor:
Mashhad University of Medical Sciences
Organization: